Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 3

Relationship between skin disease mortality as of ICD-10 and health expenditure on purchasing power parity: A multi-country level analyses

Pages
228–232
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, studies and field applications must be carried out to raise awareness about skin diseases in the male gender.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Diseases of the skin and subcutaneous tissues still cause mortality in some parts of the world.
📊
Key Findings & Data:This research aimed to examine the relationship between diseases of the skin and subcutaneous tissue-related mortality as of ICD-10 and health expenditure on purchasing power parity from the World Bank Database.
💡
Conclusion & Impact:For this reason, studies and field applications must be carried out to raise awareness about skin diseases in the male gender.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: Diseases of the skin and subcutaneous tissues still cause mortality in some parts of the world. This research aimed to examine the relationship between diseases of the skin and subcutaneous tissue-related mortality as of ICD-10 and health expenditure on purchasing power parity from the World Bank Database. Material and Methods: “Domestic private health expenditure per capita, PPP (current international $)” and “Domestic general government health expenditure per capita, PPP (current international $)” were collected from the World Bank Country Data for each country in which skin and subcutaneous tissue-related mortality were reported in the World Health Organization (WHO) ICD-10 Mortality database for 1996 to 2017. Results: A total of 13 countries were reported for mortality. Male deaths related to skin and subcutaneous tissue in Oman, Sri Lanka, Azerbaijan, Turkmenistan, and Ukraine were higher than female deaths. In Seychelles, Brunei Darussalam, Syrian Arab Republic, Belarus, Kazakhstan, and Russian Federation, female deaths were higher than male deaths. The correlation direction was positive, showing that an increase in country codes in the WHO ICD-10 list causes an increase in deaths. Conclusion: Deaths resulting even from skin diseases with an extremely low mortality level have been reported. At this point, when gender is discriminated, it is seen that women and men differ significantly in skin diseases. For this reason, studies and field applications must be carried out to raise awareness about skin diseases in the male gender.

🔖

Cite This Article

AKTAŞ, H. (2022). Relationship between skin disease mortality as of ICD-10 and health expenditure on purchasing power parity: A multi-country level analyses. Annals of Medical Research, Cilt: 29 - Sayı: 3, 228–232. https://ajindex.com/articles/445582

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wang X, Liu P, Xu T, Chen Y, Yu Y, et al. China-UK partnership for global health: practices and implications of the Global Health Support Programme 2012–2019. Glob Health Res Policy. 2020 Mar 20; 5: 13. doi: 10.1186/s41256–020–00134–7
  2. Foucart R, Wan C. Strategic decentralization and the provision of global public goods. Journal of Environmental Economics and Management. 2018; 92(1): 537–558
  3. Zhang J, Swartz BC. Public diplomacy to promote Global Public Goods (GPG): Conceptual expansion, ethical grounds, and rhetoric. Public Relations Review. 2009; 35(4): 382–387
  4. Boucher V, Bramoullé Y. Providing global public goods under uncertainty. Journal of Public Economics. 2010; 94(9–10): 591–603
  5. Kapur D. The Common Pool Dilemma of Global Public Goods: Lessons from the World Bank’s Net Income and Reserves. World Development. 2002; 30(3): 337–354
  6. Faunce TA. Global Public Goods. Encyclopedia of Applied Ethics (Second Edition). 2012: 523–528
  7. Cole AL, Wood WA Jr, Muluneh B, Lund JL, Elston Lafata J, Dusetzina SB. Comparative Safety and Health Care Expenditures Among Patients With Chronic Myeloid Leukemia Initiating First-Line Imatinib, Dasatinib, or Nilotinib. JCO Oncol Pract. 2020; 20: JOP1900301. doi: 10.1200/JOP.19.00301
  8. Dean EB, French MT, Mortensen K. Food insecurity, health care utilization, and health care expenditures. Health Serv Res. 2020 Mar 18. doi: 10.1111/1475–6773.13283
  9. Patel J, Shah D, Sambamoorthi U. Healthcare Expenditures Associated with Persistent Opioid use Among Adults with Chronic Non-Cancer Pain Conditions: A Retrospective Cohort Study. J Pain Palliat Care Pharmacother. 2020 Mar 18:1–15. doi: 10.1080/15360288.2020.1734710
  10. Hay RJ. Skin Disease in the Tropics and the Lessons that can be Learned from Leprosy and Other Neglected Diseases. Acta Derm Venereol. 2020; 24. doi: 10.2340/00015555–3469
  11. Zhou S, Li Q, Wu H, Lu Q. The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases. Cell Mol Immunol. 2020; 17: 335–346. doi: 10.1038/s41423–020–0399–6
  12. Kowalewska B, Cybulski M, Jankowiak B, Krajewska-Kułak E. Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross- Sectional Study. Dermatol Ther (Heidelb). 2020; 10: 413–430. doi: 10.1007/s13555–020–00368-w
  13. Cárcano CBM, de Oliveira CZ, Paiva BSR, Paiva CE. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health